Skip to content

remedent

Active
Public limited companyfounded 200125 yrs activeZuiderlaan 1-3, 9000 Gent, BelgiumKBO/BCE: BE 0474.973.168
Summary

remedent has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.3m and a net result of -€385,552. Equity is shrinking by ~3.5% per year across the filed fiscal years. Its solvency ranks better than 59% of 140 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).

Risk analysisWatch ReportCompare
remedentActiveChecked score 65/100
Risk analysis ReportCompare

Overview

Activity
Manufacture of medical and dental instruments and supplies
NACE 32500Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21209NACE 24422
1 site
Size
€62,168turnover 2025
Staff
2.6 FTE
Equity
€2.3m
Loss
-€385,552
Financial health
65 Healthy Checked score 2025
Bankruptcy chance 12 m
1.1%
Structure
Parent
Remedent Inc
Holdings
4
Accounts 2 d early0 of 9 deeds read
Why 65- Liquidity: current ratio 1.44, cash €3,780- Loss of €385,552, the second in a row (FY 2025)- 1 of the last 3 late+ Equity €2.3m (55.9% of total assets)Show the evidence

Checked score

Score 2025
65 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Better than 33% of its sector peers (NACE 32, micro)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency 81-3
equity 55.9% of total assets
Liquidity 29-3
short-term debt 43.3% · cash 0.1%
Profitability 5-3
return on assets -9.6%
Bankruptcy probability, 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (1,137 companies)
Last 24 months 11-2024: 0.6%lowest value 12-2024: 0.7%▲ +22.6% vs 11-2024 01-2025: 1.2%▲ +66.8% vs 12-2024 02-2025: 1.2%▲ +4.8% vs 01-2025 03-2025: 1.5%▲ +25.2% vs 02-2025 04-2025: 2.7%▲ +79.5% vs 03-2025highest value 05-2025: 2.7%● 0.0% vs 04-2025highest value 06-2025: 2.7%● 0.0% vs 05-2025highest value 07-2025: 2.4%▼ -9.8% vs 06-2025 08-2025: 2.4%▼ -1.6% vs 07-2025 09-2025: 1.4%▼ -43.6% vs 08-2025 10-2025: 1.5%▲ +7.8% vs 09-2025 11-2025: 1.0%▼ -34.4% vs 10-2025 12-2025: 1.0%● 0.0% vs 11-2025 01-2026: 1.0%● 0.0% vs 12-2025 02-2026: 1.0%● 0.0% vs 01-2026 03-2026: 1.0%● 0.0% vs 02-2026 04-2026: 1.0%▲ +2.2% vs 03-2026 05-2026: 1.0%● 0.0% vs 04-2026 06-2026: 1.0%▲ +1.4% vs 05-2026 07-2026: 1.0%▲ +1.4% vs 06-2026 08-2026: 1.0%▲ +2.8% vs 07-2026 09-2026: 1.0%▼ -1.2% vs 08-2026 10-2026: 1.1%▲ +9.6% vs 09-2026
  • Liquidity: current ratio 1.44, cash €3,780 raises the probability
  • Loss of €385,552, the second in a row (FY 2025) raises the probability
  • 1 of the last 3 late raises the probability
  • Equity €2.3m (55.9% of total assets) lowers the probability
Credit up to €6,000 at 30 days acceptable
Liquidity tight (current ratio 1.44 against 1.52 in 2024; short-term debt: 43.3% and cash: 0.1% of total assets), and 44.1% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 32, micro). Better than this share of them on solvency 63%, liquidity 22%, profitability 14%, growth against the median 33%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 05-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Liquidity: current ratio 1.44, cash €3,780
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · Loss of €385,552, the second in a row (FY 2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
raises risk · 1 of the last 3 late
In the bankruptcy model this factor raises the probability.
NBB · filings
lowers risk · Equity €2.3m (55.9% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
19202122232425
2019 to 2025 · latest year -€385,552
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 29-10-2025, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 d early
2024
274 d late
2023
22 d late
2022
41 d early
2021
79 d early
2020
66 d early
2019
22 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 12 days after the deadline; the sector median for financial year 2024 is 2 days before the deadline, and 40% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today. Usually files around 29 October (4 of the last 5 filed years within 77 days of that day).
Companies Code · seven months
Position in the running window
31-03-2026 close06-10-2026 today31-10-2026 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · full…
  2. Annual accounts filedfiscal year 2024 · full…
  3. Weakest financial yearnet -€385,552

Key points

  • Risk: 3 loss-making years in a rowloss fiscal year 2025 -€385,552 View
  • Caution: Among the weakest 10% on net resultsector median €37,677 · 139 companies -€385,552 View
  • Caution: Result fell in 2025from -€260,324 to -€385,552 ▼ 48.1% View
  • Controlled by Remedent Inc parent View

By topic

Financials

Fiscal year
2025
Turnover
€62,168
Loss
-€385,552
Solvency
55.9%
Turnover▼ 11.0%
Net result
20192025
Go to Financials

Timeline

Events
13
Since
2016
Next accounts
by 31-10-2026
  1. 29-10-2025Annual accounts filed
  2. 01-08-2025Annual accounts filed
  3. 31-03-2025Weakest financial year
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Manufacture of medical and dental instruments and suppliesNACE 32500
Founded
11-06-2001
Year ends
31-03
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure